Confluence Investment Management LLC raised its position in shares of Exponent Inc. (NASDAQ:EXPO) by 0.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,594 shares of the company’s stock after buying an additional 25 shares during the period. Confluence Investment Management LLC’s holdings in Exponent were worth $1,962,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. BlackRock Institutional Trust Company N.A. increased its position in shares of Exponent by 0.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 644,090 shares of the company’s stock worth $32,855,000 after buying an additional 3,931 shares during the last quarter. State Street Corp increased its position in shares of Exponent by 2.1% in the first quarter. State Street Corp now owns 503,133 shares of the company’s stock worth $25,658,000 after buying an additional 10,457 shares during the last quarter. GW&K Investment Management LLC increased its position in shares of Exponent by 17.2% in the second quarter. GW&K Investment Management LLC now owns 316,076 shares of the company’s stock worth $18,462,000 after buying an additional 46,418 shares during the last quarter. Panagora Asset Management Inc. increased its position in shares of Exponent by 66.6% in the first quarter. Panagora Asset Management Inc. now owns 133,631 shares of the company’s stock worth $6,816,000 after buying an additional 53,421 shares during the last quarter. Finally, Roffman Miller Associates Inc. PA increased its position in shares of Exponent by 4.3% in the second quarter. Roffman Miller Associates Inc. PA now owns 132,122 shares of the company’s stock worth $7,717,000 after buying an additional 5,410 shares during the last quarter. 91.46% of the stock is currently owned by institutional investors and hedge funds.
Exponent Inc. (NASDAQ:EXPO) traded up 0.71% during mid-day trading on Wednesday, reaching $50.79. 44,183 shares of the company’s stock traded hands. The stock’s 50 day moving average is $50.36 and its 200-day moving average is $51.90. Exponent Inc. has a 52 week low of $44.11 and a 52 week high of $59.71. The stock has a market capitalization of $1.32 billion, a PE ratio of 29.02 and a beta of 0.81.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Tuesday, July 19th. The company reported $0.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The company earned $77.30 million during the quarter, compared to analysts’ expectations of $80.46 million. Exponent had a net margin of 15.13% and a return on equity of 16.02%. On average, equities analysts anticipate that Exponent Inc. will post $1.59 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Stockholders of record on Friday, September 2nd were given a dividend of $0.18 per share. The ex-dividend date was Wednesday, August 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.42%. Exponent’s dividend payout ratio (DPR) is presently 41.62%.
A number of research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Exponent from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Cantor Fitzgerald started coverage on shares of Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 target price on the stock. Finally, Avondale Partners started coverage on shares of Exponent in a research report on Thursday, July 7th. They set a “market perform” rating and a $60.00 target price on the stock.
In other news, insider Paul Boehm sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $51.42, for a total transaction of $257,100.00. Following the transaction, the insider now directly owns 29,045 shares in the company, valued at $1,493,493.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Paul R. Johnston sold 5,578 shares of the firm’s stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $58.15, for a total transaction of $324,360.70. Following the transaction, the chief executive officer now owns 64,458 shares in the company, valued at $3,748,232.70. The disclosure for this sale can be found here. Insiders own 3.50% of the company’s stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.